original ) (raw )Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study
Francis Zech
Journal of Internal Medicine, 1997
View PDFchevron_right
Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus
Jim Julian
Blood, 2001
View PDFchevron_right
Intraindividual consistency of the activated protein C resistance phenotype
Domenico madeo
British Journal of Haematology, 2004
View PDFchevron_right
Resistance to Activated Protein C in Thrombophilic Patients in Rio de Janeiro
Telma Gadelha
Acta Haematologica, 1998
View PDFchevron_right
Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
M. Mowinckel
Journal of Thrombosis and Haemostasis, 2007
View PDFchevron_right
Diagnosis strategies in activated protein C resistance: is genotyping still necessary?
J. Schved
Clinical and Laboratory Haematology, 1997
View PDFchevron_right
Activated protein C resistance as a basis for venous thrombosis
Bengt Zoller
The American Journal of Medicine, 1996
View PDFchevron_right
-Prevalence of activated protein c resistance due to
mohamed FARAG
View PDFchevron_right
Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants
Véronique Regnault , Coenraad Hemker
Thrombosis and haemostasis, 2003
View PDFchevron_right
Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation
Gualtiero Palareti
British Journal of Haematology, 1996
View PDFchevron_right
Activated Protein C Resistance in Adult Sudanese Patients diagnosedwith Deep Vein Thrombosis
Anwaar Kordofani
Science Journal of Medicine and Clinical Trials, 2014
View PDFchevron_right
Activated protein C resistance in patients with peripheral vascular disease
Bengt Lindblad
Journal of Vascular Surgery, 1998
View PDFchevron_right
Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II
Ronald Carrasco
British Journal of Haematology, 2002
View PDFchevron_right
Resistance to Activated Protein C as an Additional Genetic Risk Factor in Hereditary Deficiency of Protein S
Bengt Zöller
View PDFchevron_right
High sensitivity and specificity of a coagulation assay for the detection of heterozygous and homozygous factor V Leiden--based resistance to activated protein C
Manuel Schmidt
Blood
View PDFchevron_right
Variable interference of activated protein C resistance in the measurement of protein S activity by commercial assays
Patrizia Della Valle
Thrombosis Research, 1995
View PDFchevron_right
A chromogenic assay for activated protein C resistance
Berta Moritz
British Journal of Haematology, 1995
View PDFchevron_right
FAMILIAL THROMBOPHILIA Resistance to activated protein C and protein· S deficiency
Bengt Zöller
Doctoral Thesis, 1996
View PDFchevron_right
Activated protein C resistance assay and factor V Leiden
Harald Mangge
2014
View PDFchevron_right
Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women
Stella Thomassen
British Journal of Haematology, 2003
View PDFchevron_right
Activated protein C resistance: the influence of ABO-blood group, gender and age
Emmanuel Favaloro
Thrombosis research, 2006
View PDFchevron_right
Activated protein C resistance in patients with arterial ischemic stroke
Gustavo Saposnik
2001
View PDFchevron_right
Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM
Judith Greengard
Blood
View PDFchevron_right
Activated Protein C Resistance Assay Detects Thrombotic Risk Factors Other Than Factor V Leiden
carolyn welsh
American Journal of Clinical Pathology, 2003
View PDFchevron_right
Detection of a common mutation in factor V gene responsible for resistance to activated protein C causing predisposition to thrombosis
Nga Nguyen
Journal of Clinical Laboratory Analysis, 1997
View PDFchevron_right
Increased acquired activated protein C resistance in unselected patients with hematological malignancies
H. Negaard , M. Mowinckel
Journal of Thrombosis and Haemostasis, 2008
View PDFchevron_right
Rapid Publication Identification of the Same Factor V Gene Mutation in 47 out of 50 Thrombosis- prone Families with Inherited Resistance to Activated Protein C
Bengt Zöller , B. Dahlback
View PDFchevron_right
Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V
Tilman Hackeng
Blood, 1995
View PDFchevron_right
Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C
Aida Inbal
Blood, 1999
View PDFchevron_right